- Report
- April 2022
- 111 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- April 2023
- 135 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- February 2024
- 115 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- April 2023
- 115 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- January 2024
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- March 2024
- 200 Pages
Global
From €3717EUR$4,150USD£3,169GBP
- Report
- March 2024
- 200 Pages
Global
From €3717EUR$4,150USD£3,169GBP
- Report
- January 2024
- 200 Pages
Global
From €3717EUR$4,150USD£3,169GBP
- Report
- August 2023
- 145 Pages
Global
From €2821EUR$3,150USD£2,405GBP
- Report
- May 2024
- 160 Pages
Global
From €3538EUR$3,950USD£3,016GBP
- Report
- September 2023
- 145 Pages
Global
From €3986EUR$4,450USD£3,398GBP
- Report
- December 2023
- 165 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- May 2023
- 147 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- April 2023
- 147 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- February 2024
- 218 Pages
Global
€4474EUR$4,995USD£3,814GBP
- Report
- August 2023
- 309 Pages
Global
From €3224EUR$3,600USD£2,749GBP
- Report
- August 2023
- 139 Pages
Europe
From €1344EUR$1,500USD£1,145GBP
- Report
- August 2023
- 140 Pages
Middle East, Africa
From €1344EUR$1,500USD£1,145GBP
- Report
- August 2023
- 125 Pages
North America
From €1344EUR$1,500USD£1,145GBP
- Report
- August 2023
- 139 Pages
Asia Pacific
From €1344EUR$1,500USD£1,145GBP

Orthobiologics is a field of biotechnology that focuses on the development of products and treatments to improve musculoskeletal health. It includes the use of biological materials such as stem cells, growth factors, and proteins to repair, regenerate, and replace damaged or diseased tissues. Orthobiologics is used to treat a variety of musculoskeletal conditions, including fractures, tendon and ligament injuries, and degenerative joint diseases. It is also used to improve the healing of bone and soft tissue after surgery.
Orthobiologics is a rapidly growing field, with new products and treatments being developed to improve patient outcomes. It is becoming increasingly important in the treatment of musculoskeletal conditions, as it offers a more natural and less invasive approach than traditional treatments.
Some companies in the Orthobiologics market include Acelity, AlloSource, Arthrex, Bioventus, DePuy Synthes, Exactech, Integra LifeSciences, Medtronic, MiMedx, Orthofix, and Stryker. Show Less Read more